Cleared Special

K121224 - GENESIS HEALTH TECHNOLOGIES BLOOD GLUCOSE MONITORING SYSTEM (FDA 510(k) Clearance)

Sep 2012
Decision
152d
Days
Class 2
Risk

K121224 is an FDA 510(k) clearance for the GENESIS HEALTH TECHNOLOGIES BLOOD GLUCOSE MONITORING SYSTEM. This device is classified as a Glucose Dehydrogenase, Glucose (Class II - Special Controls, product code LFR).

Submitted by Taidoc Technology Corporation (New Taipei City, TW). The FDA issued a Cleared decision on September 19, 2012, 152 days after receiving the submission on April 20, 2012.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1345.

Submission Details

510(k) Number K121224 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 20, 2012
Decision Date September 19, 2012
Days to Decision 152 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code LFR — Glucose Dehydrogenase, Glucose
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1345